Soon-Shiong’s NantCell hauls in another $100M for immuno-oncology R&D
NantCell, one of billionaire entrepreneur Patrick Soon-Shiong's…
Agenus mortgages some vaccine royalties for $115M in R&D cash
Agenus ($AGEN) is trading away future royalties on a GlaxoSmithKline…
Bristol-Myers’ latest PD-1 win could pave the path to earlier use
Bristol Myers-Squibb ($BMY), a leader among companies at work…